Description

Retatrutide

is currently being investigated in clinical trials for the treatment of obesity and type 2 diabetes.
Initial study results show that patients on retatrutide were indeed able to achieve very significant weight reductions
– in some cases even more so than with other GLP-1 drugs such as semaglutide or tirzepatide.